Home | Welcome to Contract Pharma   
Last Updated Friday, July 11 2014
Print RSS Feed

Search Results for 'Financial Report: Alkermes'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published April 30, 2014
Manufacturing and royalty revenues down 24% in the quarter Read More »
By Kristin Brooks
Published February 27, 2014
Revenues up 14% in the quarter Read More »
By Kristin Brooks
Published January 8, 2014
Phase III programs advance Read More »
Published October 31, 2013
Revenues up 13%, loss narrows Read More »
Published July 25, 2013
Key commercial products up 22% in the quarter Read More »
Published May 23, 2013
Revenues up 25% in the quarter Read More »
Published February 1, 2013
Will no longer own shares of the former EDT business Read More »
Published January 31, 2013
Revenues up 8% in the quarter Read More »
Alkermes
By Fidelma Callanan, Sr. Director Marketing and Commercial Development
Four decades delivering contract pharma solutions for our Partners Alkermes Contract Pharma Services provid… Read More »
Published May 17, 2012
EDT merger boosts revenues Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On